LYEL•benzinga•
Lyell To Present Initial Clinical Data From Phase 1-2 Trial Of IMPT-314 CAR T-Cell Therapy For B-Cell Lymphoma At ASH 2024, Highlighting Fast Track Designation And Dual-Targeting CD19/CD20 Approach
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 5, 2024 by benzinga